NCT02876328: Partnership for Research on Ebola VACcinations
- State
- Completed
- Phase
- Phase 2
- People
- 4,789 taking part
- Started
- 27 Mar 2017
- Primary completion
- 24 Dec 2019
- Arms
- rVSVΔG-ZEBOV-GP (rVSV) vaccine + placebo boost, rVSVΔG-ZEBOV-GP (rVSV) vaccine + rVSV boost
- Results
- Posted on the registry
- 23 Aug 2016: Trial registered
- 27 Mar 2017: Trial started
- 28 Sep 2022: Trial results posted
- 20 Dec 2023: Trial completed